bromopyruvate has been researched along with Triple Negative Breast Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, JC; Li, QS; Luo, XH; Pan, JM; Xiao, WF; Yang, C; Zhang, XD | 1 |
| Feng, X; Liu, Q; Mai, B; Wang, P; Wang, X; Zhang, T | 1 |
2 other study(ies) available for bromopyruvate and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
3-Bromopyruvate Inhibits the Growth and Glucose Metabolism of TNBC Xenografts in Nude Mice by Targeting c-Myc.
Topics: Adenosine Triphosphate; Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 9; Cell Line, Tumor; Cell Proliferation; Glucose; Heterografts; Humans; Mice; Mice, Nude; Triple Negative Breast Neoplasms | 2023 |
Glycolytic inhibitors 2-deoxyglucose and 3-bromopyruvate synergize with photodynamic therapy respectively to inhibit cell migration.
Topics: Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Survival; Deoxyglucose; Drug Synergism; Fluorescent Antibody Technique; Glycolysis; Humans; Microscopy, Electron, Scanning; Photochemotherapy; Pyruvates; Tetrazolium Salts; Thiazoles; Triple Negative Breast Neoplasms | 2015 |